高血圧におけるアテノロール:それは賢明な選択ですか?
Bo Carlberg1, Ola Samuelsson, Lars Hjalmar Lindholm
1Department of Public Health and Clinical Medicine, Umeå University Hospital, SE 901 85 Umeå, Sweden.
Lancet (London, England)
|November 9, 2004
まとめ
アテノロール (ベータブロッカー) は,高血圧患者のプラセボと比較して,アウトカムを改善しませんでした. しかし,他の抗高血圧薬よりも高い死亡率と脳卒中リスクを示し,その使用を疑問視した.
科学分野:
- 心臓病学 心臓病学
- 薬理学 薬理学とは
- クリニック・トライアル 臨床試験
背景:
- アテノロールは,高血圧に対する広く使用されているベータブロッカーです.
- 臨床試験における基準薬としての適性は疑問視されている.
研究 の 目的:
- 高血圧患者の心血管疾患と死亡率に対するアテノロルの効果を体系的に検討する.
主な方法:
- ランダム化比較試験の体系的なレビューとメタ解析.
- 検索対象はコクラン図書館,MEDLINE,専門家通信などでした.
- 含まれる試験は,アテノロールをプラセボまたは他の抗高血圧薬と比較した.
主要な成果:
- プラセボと比較して,アテノロールは全因死亡率,心血管死亡率,心筋梗塞における有意な差異を示さなかった.
- アテノロールは,プラセボと比較して脳卒中リスクの低下傾向と関連していました.
- 他の抗高血圧薬と比較して,アテノロールは著しく高い死亡率と脳卒中頻度の増加を示しました.
結論:
- 高血圧患者の治療としてアテノロールの有効性と安全性は疑問視されています.
- 高血圧結果試験における基準薬としての役割は再検討されるべきである.
関連する概念動画
Errors occurring during blood pressure monitoring
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...


